在现场使用合成纳米材料对免疫细胞进行重新编程
Shihong Nie1, Yuyang Qin1,2, Liyuan Ou2
1Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Advanced materials (Deerfield Beach, Fla.)
|January 17, 2024
概括
在现场细胞疗法为复杂而昂贵的CAR-T细胞制造提供了一个有希望的替代方案,用于癌症治疗. 这种方法使用合成纳米材料来重编程体内的免疫细胞,提高可访问性.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 化学抗原受体-T (CAR-T) 细胞疗法改变了癌症治疗,但面临着制造方面的挑战.
- 高昂的成本和复杂性限制了当前采用细胞疗法的可访问性.
- 现场细胞疗法成为一种可行的替代方案,它可以直接在体内重新编程免疫细胞.
研究的目的:
- 提供合成纳米材料在现场免疫细胞重编程的概述.
- 专注于这些纳米材料在现场CAR疗法中的应用.
- 讨论挑战,并提出解决方案,用于临床翻译的 in situ 免疫细胞重编程.
主要方法:
- 核酸输送 (等离子体DNA和mRNA) 的合成纳米材料开发近期进展的审查.
- 专注于纳米材料介导的交付,用于T细胞和巨细胞的现场重编程.
- 对现场CAR疗法开发策略的分析.
主要成果:
- 合成纳米材料显示了为在位免疫细胞重编程提供遗传材料的潜力.
- 在现场CAR疗法是一个关键的重点,利用这些纳米材料.
- 确定了实现有效和安全的现场重新编程的关键挑战.
结论:
- 通过合成纳米材料实现的局部细胞疗法,为癌症免疫疗法提供了一种可扩展和可访问的方法.
- 克服当前的挑战对于在位免疫细胞重编程的临床应用至关重要.
- 需要对纳米材料设计和交付进行进一步的研究,才能充分发挥这种治疗策略的潜力.
相关概念视频
Introduction to Nuclear Reprogramming
1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


